Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Inactivated"


25 mentions found


Why some salads may be unsafe
  + stars: | 2023-08-03 | by ( Kirsi Goldynia | ) edition.cnn.com   time to read: +16 min
Even harder to contend with is the fact that the food products most susceptible to contamination are often those we eat for their health benefits – produce items. “Produce led the list; about 46% of the foodborne illness that we saw in the US could be attributable to produce. But you bring up a really great point that the processing of packaged meats may actually protect the products from pathogens. I think water is going to emerge as a huge issue. I think we’ve got systems in place that do a good job of making sure that consumers are getting good products.
Persons: Dr, Catherine Donnelly, Listeria, , Donnelly, “ Produce, ” That’s, , ” Donnelly, I’m, we’ve, Edwin Remsberg, they’re, there’s, Barack Obama’s, Bridget Bennett, Vibrio, Facebook There’s Organizations: CNN, Department of Nutrition, Food Sciences, University of Vermont, US Centers for Disease Control, CDC, , Food and Drug Administration, FDA, US Department of Agriculture, Getty, Bloomberg, Twitter, Facebook Locations: Western Washington, Cronobacter, Michigan, KFF, Vermont, hydroponics
In April, the Navy published a notice announcing the beginning of planning to scrap the USS Nimitz. But Nimitz will be only the second nuclear-powered carrier to go through deactivation and defueling. The Nimitz would only be the second American nuclear-powered carrier scheduled to be scrapped. The first is the USS Enterprise, which was commissioned in 1961 and was also the world's first nuclear-powered carrier. The private shipyard will probably be in Alabama, Texas, or Virginia, according to a draft environmental impact statement posted on a special Navy carrier disposal website.
China Approves First Homegrown mRNA Covid-19 Vaccine
  + stars: | 2023-03-23 | by ( Clarence Leong | ) www.wsj.com   time to read: 1 min
China has relied primarily on inactivated vaccines to protect its population during the pandemic. SINGAPORE—China approved its first homegrown mRNA vaccine for Covid-19, adding a key tool to combat future outbreaks of the virus that was missing due to Beijing’s reluctance to allow Western-made shots using the gene-based technology. CSPC Pharmaceutical Group Ltd.’s messenger-RNA vaccine, known as SYS6006, was given emergency-use clearance by regulators, the company said in a filing to the Hong Kong stock exchange Wednesday. The vaccine was designed to work against the latest variants of Covid-19, and also proved effective against older strains, it said.
China approves its first mRNA Covid-19 vaccine
  + stars: | 2023-03-23 | by ( Juliana Liu | ) edition.cnn.com   time to read: +1 min
Hong Kong CNN —China has approved its first Covid-19 vaccine based on mRNA technology, months after the country lifted strict pandemic measures. The vaccine targets the Omicron variant and was tested in China with over 5,500 people, it added. “This is a positive step because there is strong scientific evidence that mRNA vaccines do much better than non-MRA vaccines,” Jin Dong-yan, a professor in molecular virology at the University of Hong Kong, told CNN. Until now, China has approved only inactivated vaccines made by Sinovac Biotech and Sinopharm Group, two Beijing-based drugmakers. The inactivated vaccines have been found to elicit lower levels of antibody response compared to ones using the newer messenger RNA technology.
Companies Valneva SE FollowPARIS, March 2 (Reuters) - Vaccines company Valneva (VLS.PA) said on Thursday that its inactivated COVID-19 vaccine candidate product VLA2001 had its shelf life extended to 21 months from 18 months previously, as it unveiled regulatory updates for the product. "As previously announced, Valneva will not invest in further development of the vaccine, in the absence of a new partnership. It is, however, completing remaining clinical studies and submissions as agreed with regulators," added Valneva. Reporting by Sudip Kar-Gupta; Editing by Christian SchmollingerOur Standards: The Thomson Reuters Trust Principles.
DAVOS, Switzerland, Jan 18 (Reuters) - Moderna (MRNA.O) chief executive Stephane Bancel said on Wednesday the U.S. company was in active discussions to supply COVID-19 vaccines to China. Beijing has so far insisted on using only Chinese-made COVID-19 vaccines for its own population, but the country is beset by a raging COVID outbreak following a U-turn from Beijing on previously ultra-tight anti-pandemic curbs. China-made COVID vaccines are of the inactivated virus type and not based on the messenger RNA technology used in the most widely used shots developed by Moderna and Pfizer (PFE.N)-BioNTech (22UAy.DE). As regards cancer treatments, Moderna has been working with Merck (MRK.N) on an experimental vaccine against melanoma based on the mRNA technology used in successful COVID-19 vaccines. The company, whose COVID-19 vaccines are made in the United States and Switzerland, is building or planning to build plants in Canada, Australia, Britain and Kenya, he said.
China's 'great migration' kicks-off under shadow of COVID
  + stars: | 2023-01-07 | by ( Casey Hall | ) www.reuters.com   time to read: +6 min
BORDER REOPENINGSunday marks the reopening of China's border with Hong Kong and the end of China's requirement for inbound international travellers to quarantine. More than a dozen countries are now demanding COVID tests from Chinese travellers, as the World Health Organisation said China's official virus data underreported the true extent of its outbreak. In Shanghai, for example, the city government on Friday announced an end to free PCR tests for residents from Jan. 8. China has relied on nine domestically-developed COVID vaccines approved for use, including inactivated vaccines, but none have been adapted to target the highly-transmissible Omicron variant and its offshoots currently in circulation. China reported three new COVID deaths in the mainland for Friday, bringing its official virus death toll to 5,267, one of the lowest in the world.
Chinese-made mRNA vaccine starts trial production
  + stars: | 2023-01-07 | by ( ) www.reuters.com   time to read: +1 min
SHANGHAI, Jan 7 (Reuters) - China's CanSino Biologics Inc (6185.HK) has entered "test production phase" for its COVID-19 mRNA booster vaccine, the company said in a post on its social media account late on Thursday. The CanSino booster vaccine is one of China's first home-grown potential vaccines based on mRNA technology similar to that employed in vaccines produced internationally by Pfizer-BioNTech and Moderna. On Thursday, CanSino also reported "positive" interim data from a mid-stage clinical trial in a filing to the Hong Kong stock exchange. According to CanSino, the first phase of its mRNA vaccine production could produce 100 million doses. Reporting by Casey Hall; Editing by Jacqueline WongOur Standards: The Thomson Reuters Trust Principles.
EU offers China free vaccines as COVID-19 infections surge
  + stars: | 2023-01-03 | by ( ) www.reuters.com   time to read: +2 min
BRUSSELS, Jan 3 (Reuters) - The European Union has offered free COVID-19 vaccines to China, the EU executive said on Tuesday, as infections there surged following Beijing's relaxation of its "zero-COVID" policies. China has not responded to the offer yet, a spokesperson for the European Commission told journalists at a regular briefing. He did not specify the amount of vaccines the EU was offering or their manufacturers. "In view of the COVID situation in China, (Health) Commissioner Stella Kyriakides has reached out to her Chinese counterparts to offer EU solidarity and support," he said. Last month, Germany shipped 11,500 BioNTech (22UAy.DE) COVID vaccines to German companies and embassy and consulate locations in China for use by German nationals there.
[1/2] The BioNTech logo is seen at the booth of Fosun Pharmaceutical (Group) at the 2021 China International Fair for Trade in Services (CIFTIS) in Beijing, China September 3, 2021. REUTERS/Florence LoHONG KONG, Dec 27 (Reuters) - China's Shanghai Fosun Pharmaceutical Group (600196.SS) said users of its mobile health app in China can now register to take COVID-19 booster shots in Hong Kong using BioNTech's (22UAy.DE) vaccine. BioNTech and its partner for China - Fosun - were granted approval for their COVID-19 vaccine that is adapted for the BA.4 and the BA.5 subvariants of Omicron for people aged 12 and older in Hong Kong, the German company said on Dec. 23. The vaccine is the first and currently only variant-adapted vaccine available as a booster dose for individuals 12 years and older that has been granted approval in Hong Kong, BioNTech said at the time. A shipment of BioNTech COVID-19 vaccines meant for German nationals in China arrived at the German embassy in Beijing last week as cases in China soared after policymakers dropped nearly all of previous epidemic control protocols.
Some fear China’s Covid death toll could rise above 1.5 million in coming months. It was not immediately clear which, if any, of these deaths were included in official death tolls. “The (official) number is clearly an undercount of Covid deaths,” said Yanzhong Huang, a global health specialist at the Council on Foreign Relations (CFR), a U.S. think tank. Overseas-developed vaccines are unavailable in mainland China to the general public, which has relied on inactivated shots by local manufacturers for its vaccine rollout. While China’s medical community in general doesn’t doubt the safety of China’s vaccines, some say questions remain over their efficacy compared to foreign-made mRNA counterparts.
Reuters could not immediately establish if the deaths were due to COVID. The NHC also reported 1,995 symptomatic infections for Dec. 18, compared with 2,097 a day earlier. A hashtag on the two reported COVID deaths quickly became the top trending topic on China's Twitter-like Weibo platform on Monday morning. But it is not just the elderly that are wary of vaccines in China. While China's medical community in general doesn't doubt the safety of China's vaccines, some say questions remain over their efficacy compared to foreign-made mRNA counterparts.
"I don't trust it," she said, speaking on the condition that only her first name be used. It has also yet to introduce its own version of an mRNA vaccine. "At least a half of doctors and educated people wanted to get the mRNA ones and refused to get the Chinese ones," Lei said. "After a while, people see no hope and also they are kind of forced to get the Chinese ones, so they had to accept it. Lei said many of her friends are looking to visit the neighbouring Chinese territory of Macau, where mainlanders can receive mRNA vaccines.
But for a place that until earlier this month assiduously tracked every case, there is now no clear data on the extent of the virus’ spread. Customers queue at a pharmacy in Beijing, China, on Tuesday, December 13. Authorities on Wednesday morning reported 2,249 symptomatic Covid cases nationally for the previous day, 20% of which were detected in the capital. A closed Covid testing booth in Beijing, China, on Tuesday, December 13. Chinese state media has since warned people the preserved fruit is not a Covid remedy nor a substitute for medicine.
Across the country, however, some parts of residential communities and buildings designated high risk by authorities are still locked down. A QR code for Covid-19 contact tracing displayed at the entrance to a subway station in Shanghai, China, on Monday. Top health officials on November 28 announced a new plan to bolster elderly vaccination rates, but such measures will take time, as will other preparations for a surge. Minimizing the worst outcomes in a transition out of zero-Covid depends on that preparation, according to Cowling. From that perspective, he said, “it doesn’t look like it would be a good time to relax the policies.”
Public health officials subsequently confirmed the virus was in fact spreading widely after sewage samples from five other New York counties tested positive. The virus spreading in the New York area is related to a strain used in the oral polio vaccine. Other countries do still use the oral polio vaccine because it is cheap, effective, easy to administer and generally safe. The U.S. uses an inactivated polio vaccine administered as a series of shots. The oral vaccine is very effective at blocking transmission and is typically used to crush outbreaks.
But it still refuses to use Western mRNA vaccines to innoculate the population more quickly. China's hesitancy to use Western vaccine technology is contributing to the mass protests against its COVID-19 restrictions. Despite that, China is still refusing to approve and distribute Western vaccines to innoculate its citizens. In lieu of the Western vaccines, which are based on mRNA, China has been relying on its own brand of jabs, which rely on inactivated, or killed, virus. Germany this week suggested China should use Western vaccines to speed up the process and protect the country from the virus, Politico reported.
CanSino rolls out inhalable COVID vaccine in Tianjin, Beijing
  + stars: | 2022-11-09 | by ( ) www.reuters.com   time to read: +2 min
BEIJING, Nov 9 (Reuters) - Beijing residents can start making appointments for an inhalable COVID booster made by CanSino Biologics, media reported on Thursday, while those in Tianjin city can now get it as the Chinese pharmaceutical firm distributes more supplies. read moreThe financial hub of Shanghai and 13 cities in the eastern province of Jiangsu have already introduced the CanSino vaccine as a booster, the company said. Appointments for the vaccine in the capital can be booked on a mobile phone app for residents of one district, the official Beijing Business Daily reported on Thursday. China has relied on domestically produced, inactivated shots and has yet to import, or introduce its own version of an mRNA vaccine. Regarding the efficacy of its vaccine, Hong Kong-listed CanSino (6185.HK) said in a statement on Wednesday studies showed "using Convidecia Air as a heterologous booster generated much stronger immune responses than those induced by a homologous inactivated vaccine booster".
China rolls out first inhalable COVID vaccine
  + stars: | 2022-10-28 | by ( Casey Hall | ) www.reuters.com   time to read: +3 min
Chinese regulators approved the vaccine, produced by Chinese pharmaceutical firm CanSino Biologics (6185.HK), for use as a booster in September. His hospital is among those administering the new vaccine, which will be used as well as regular injected shots. The country has relied on domestically produced, inactivated shots and has yet to import, or introduce its own version, of an mRNA vaccine. Loh is hopeful that results from Shanghai's foray into inhaled vaccines will encourage other countries to follow suit. "I think inhaled vaccines for respiratory illness like COVID-19 will be the future," he said.
"There will be lots of thought and discussion about the reintroduction of an oral polio vaccine into the United States," she said. The oral polio vaccine is much more effective at stopping transmission of the virus and is normally used to quash outbreaks. The novel oral polio vaccine was developed to stop poliovirus outbreaks caused by the less stable older version of the vaccine, according to the Global Polio Eradication Initiative. Any decision to use the novel oral polio vaccine would require either an approval or emergency use authorization from the Food and Drug Administration. The World Health Organization recommends that countries using the inactivated vaccine, such as the U.S., consider deploying the novel oral polio vaccine if the inactivated shots don't stop the outbreak.
Kathy Hochul has extended the state of emergency declared in response to the spread of poliovirus after sewage tested positive in Brooklyn and Queens. The New York State Department of Health, in a statement Tuesday, said the sewage sample that tested positive in Brooklyn and Queens is genetically linked to the virus that paralyzed an unvaccinated adult in Rockland County over the summer. A total of 70 sewage samples have tested positive for poliovirus in the New York City metropolitan area so far, according to New York state health officials. More than 28,000 doses of polio vaccine have been administered since July in Rockland, Orange, Sullivan and Nassau countries, according to state health officials. State, national, and global health authorities believe the poliovirus found in New York originated from a country that still uses the oral polio vaccine.
Ministerul Afacerilor Externe și Integrării Europene (MAEIE) a actualizat vineri, 2 iulie, condițiile de călătorie a cetățenilor R. Moldova în alte state în contextul pandemiei de COVID-19. România:Începând cu 1 iunie 2021, au fost anulate restricțiile privind intrarea în România a cetățenilor străini și apatrizilor. Prin urmare, toți cetățenii Republicii Moldova, posesori de pașapoarte biometrice, pot intra în România, indiferent de scopul călătoriei. Bulgaria:Cetățenii Republicii Moldova au dreptul de a intra pe teritoriul Bulgariei la prezentarea unuia din următoarele documente:a) Document care atestă finalizarea schemei de vaccinare contra COVID-19. Grecia:Cetățenii Republicii Moldova, posesori ai pașaportului biometric, sunt exceptați de la restricțiile de intrare pe teritoriul Republicii Elene.
Persons: Janssen, Ad26, COV2, . Organizations: Externe, Integrării Europene, Confederația Elvețiană, OMS, Sputnik, Rapid Locations: Moldova, România, Bulgaria, Grecia, Austria, Ucraina, Republicii Moldova, Republica Moldova, Ucrainei, 02.06.2021, Bulgariei, AZD1222, Covishield, Inactivated, Republicii Elene, Greciei, PCR
Potrivit informațiilor prezentate, la plecarea în Bulgaria, cetățenii R. Moldova trebuie să prezinte un document care atestă finalizarea schemei de vaccinare împotriva noului coronavirus sau rezultatul negativ al testării COVID-19. Ambasada R. Moldova în Republica Bulgaria informează că, în conformitate cu ordinul РД-01-374 din 27.05.2021 al Ministerului Sănătății al Republicii Bulgaria, au fost stabilite următoarele reguli de intrare și tranzitare a teritoriului Republicii Bulgaria pentru perioada 27.05.2021 – 31.07.2021. Se permite intrarea pe teritoriul Republicii Bulgaria la prezentarea unuia dintre urmatoarele documente:Document care atestă finalizarea schemei de vaccinare contra COVID-19. Se admite ca dovadă a schemei de vaccinare finalizate administrarea combinată a unei doze Vaxzevria/ AZD1222 (Astrazeneca) și a unei doze Comirnaty/ BNT162b2 (Pfizer-BioNTech). Potrivit autorităților, se permite tranzitarea teritoriului Republicii Bulgaria cu condiția garantării părăsirii imediate a țării.
Persons: Janssen, Ad26, COV2 Organizations: Ministerului Sănătății, Sputnik, PCR Locations: Moldova, Republica Bulgaria, Bulgaria, 27.05.2021, Republicii Bulgaria, AZD1222, Covishield, Inactivated, Bulgariei
531 din 11 mai 2021 a fost prelungită starea de alertă pe întreg teritoriul țării începând cu data de 13 mai 2021. Pentru informații oficiale privind categoriile cetățenilor exceptate de a intra pe teritoriul României, precum și legislația în vigoare privind starea de alertă accesați pagina electronică. Ulterior, trebuie să prezinte un al doilea test PCR efectuat în Republica Cehă, cel târziu la 5 zile de la sosire. Autoizolarea este obligatorie până la depunerea unui al doilea test negativ. LetoniaÎn conformitate cu hotărârea guvernului Republicii Letonia a fost anulată starea de urgență în țară.
Persons: Excepție, Janssen, Ad26, COV2, Autoizolarea, . Organizations: Federația, Federației Ruse, Guvernului, PCR, Sputnik, Uniunii Europene, Sănătății, Externe Locations: Moldova, Federația Rusă, 18.05.2021, Federației Ruse, rusă, Rusiei, România, României, 14.05.2021, Republica Moldova, Ucraina, Ucrainei, Republicii Moldova, Bulgaria, Republicii Bulgaria, Bulgariei, AZD1222, Covishield, Inactivated, Cehia, Republica Cehă, Estonia, Estoniei, UE, Grecia, Australia, Macedonia de Nord, Emiratele Arabe Unite, Statele Unite ale Americii, Regatul Unit al Marii Britanii, Irlandei de Nord, Israel, Canada, Belarus, Bahrain, Noua Zeelandă, Republica Coreea, Qatar, China, Kuwait, Rwanda, Rusia, Arabia Saudită, Serbia, Singapore, Thailanda, Republica Elenă, Italia, Republicii Italiene, Italiei, Republica Italiană, Letonia, Republicii Letonia, Lituania, Republicii Lituania, . Portugalia
Ambasada Republicii Moldova în Republica Bulgaria informează că au fost stabilite următoarele reguli de intrare și tranzitare a teritoriului Republicii Bulgaria pentru perioda 1.05.2021 - 31.05.2021. Se permite intrarea pe teritoriul Republicii Bulgaria la prezentarea unuia dintre urmatoarele documente:a) Document care atestă finalizarea schemei de vaccinare contra COVID-19. Documentul trebuie să conțină numele persoanei conform documentului de călătorie, datele instituției medicale care a efectuat analiza, data când a fost efectuată analiza conform metodei PCR sau test antigen, indicarea cu grafie latină a metodei (PCR sau RAT) și rezultatul Pozitiv, care permite interpretarea documentului. Se permite tranzitarea teritoriului Republicii Bulgaria cu condiția garantării părăsirii imediate a țării. Testul PCR nu este obligatoriu pentru persoanele ce intenționează să efectueze tranzitarea teritoriului Republicii Bulgaria.
Persons: Janssen, Ad26, COV2 Organizations: Sputnik, PCR Locations: Republicii Moldova, Republica Bulgaria, Republicii Bulgaria, AZD1222, Covishield, Inactivated
Total: 25